Floatz logo

IVABRADINE

Long COVID

Kanecia Obie ZimmermanSmall moleculePhase 2Active
B
62/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
47/ 100
Competitive Position
89/ 100

Competitive context

31 Active assets in the Long COVID cohort.

View all 31

Same molecule, other indications

IVABRADINE is also rated in:

dysautonomiaDormant
CCC
Indicative ·
53 / 100
View asset →
cancer-related conditionDormant
CCC
Indicative ·
53 / 100
View asset →
myocardial ischemiaDormant
CCC
Indicative ·
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →